ERS/EULAR guidelines provide critical recommendations for managing ILD in connective tissue diseases, including idiopathic inflammatory myopathies (ref: Antoniou doi.org/10.1016/j.ard.2025.08.021/)
Lymphatic dysfunction linked to disease pathogenesis in Duchenne muscular dystrophy, highlighting chronic inflammation's role (ref: Subramanian doi.org/10.1073/pnas.2505656122/)
Overexpression of Jagged-1 shows promise in enhancing muscle regeneration in Duchenne muscular dystrophy models (ref: de Souza Leite doi.org/10.1073/pnas.2506437122/)
Statin use in type 1 diabetes is associated with reduced all-cause mortality and cardiovascular disease risk (ref: Blais doi.org/10.1016/j.jacc.2025.07.013/)
Anti-MDA5+ dermatomyositis cases have increased post-SARS-CoV-2 infection, suggesting a link between viral infections and autoimmune responses (ref: Lattarulo doi.org/10.3389/fimmu.2025.1565803/)
Exercise and rehabilitation strategies show promise in improving outcomes for patients with myopathies, emphasizing the need for tailored approaches (ref: Dengiz doi.org/10.1371/journal.pone.0332308/)
Genetic studies reveal a heterozygous deletion in SPTAN1 as a cause of distal myopathy, underscoring the importance of genetic testing (ref: Van de Vondel doi.org/10.1038/s41431-025-01938-2/)